FPA Signs Coalition Letter Sent to Members of the U.S. Senate Committee on Health, Education, Labor and Pensions Opposing an Amendment to S. 4348

The undersigned organizations oppose provisions added to S. 4348, the “Food and Drug Administration Safety and Landmark Advancement Act” (FDASLA) via an amendment from Sen. Maggie Hassan (D-NH) on food packaging and PFAS that could have adverse, unintended consequences. These provisions would prohibit introducing food packaging that contains PFAS into interstate commerce. The Food, Drug, and Cosmetic Act (P.L. 75-717, FDCA) does not define food packaging, only food contact substances. Introducing a new, undefined term into the FDCA would make it impossible for the Food and Drug Administration (FDA) to implement the legislation in a legally sustainable manner. The amendment would also have adverse, unintended consequences, including the availability of life-saving medical packaging options and packaging for dietary supplements.